Real-World Use of Botulinum Neurotoxin Type A for Hyperkinetic Movement Disorders: Insights From a French Nationwide Registry (2015-2023)

Toxicon 2026

View at publisher
Authors: Marion Simonetta‐Moreau, Pierre Karam, Anne Forestier, Bertrand Degos
DOI: 10.1016/j.toxicon.2025.108871
Cited by: 0

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Neurological disorders and treatments Glycogen Storage Diseases and Myoclonus

Publication details

Journal / source
Toxicon
Volume
271
Pages
108871–108871
Publication date
8 January 2026
Language
EN